Company Monitoring Page for Boehringer-Ingelheim

latest headlines for company on cafepharma

EASD: Lilly, BI tout new Jardiance kidney analysis as rival J&J nears FDA nod
Fierce Pharma
Tue, 09/17/19 - 11:00 am
Tags:
Eli Lilly, Boehringer Ingelheim, Jardiance, kidney disease, JNJ, EASD
ICER dings Novo's new oral diabetes drug
Biopharma Dive
Wed, 09/11/19 - 11:41 pm
Tags:
Novo Nordisk, diabetes, ICER, oral semaglutide, Eli Lilly, Boehringer Ingelheim, Jardiance, Ozempic
Boehringer Ingelheim’s Ofev secures FDA approval for SSc-ILD
Pharmaceutical Business Review
Mon, 09/9/19 - 10:32 am
Tags:
Ofev, SSc-ILD, Boehringer Ingelheim, FDA
After inking a string of pipeline deals, Boehringer Ingelheim is doing a makeover of the top executive team
Endpoints
Mon, 08/26/19 - 10:53 pm
Tags:
Boehringer Ingelheim, R&D
Companies file suit in Canada challenging new rules to lower drug prices
Yahoo/Reuters
Sun, 08/25/19 - 05:10 pm
Tags:
drug pricing, Canada, Janssen, Merck, Bayer, Servier, Boehringer Ingelheim
MD Anderson and Boehringer Ingelheim to Partner on Cancer, Found a Virtual R&D Center
BioSpace
Mon, 08/12/19 - 05:29 pm
Tags:
Boehringer Ingelheim, MD Anderson Cancer Center, cancer, R&D
Boehringer posts solid first half as business revamp beds in
PM Live
Fri, 08/2/19 - 11:44 pm
Tags:
Boehringer Ingelheim, earnings, Spiriva, Jardiance
Looking for Ofev follow-up, Boehringer picks up Bridge Biotherapeutics' IPF med for $50M
Fierce Biotech
Thu, 07/18/19 - 11:38 am
Tags:
Boehringer Ingelheim, Bridge Biotherapeutics, Ofeva, IPF, BBT-877
Boehringer buys up cancer vaccine player, eyes oncology combo strategy
Fierce Biotech
Mon, 07/15/19 - 10:05 am
Tags:
Boehringer Ingelheim, M&A, Amal Therapeutics
Boehringer races to catch up in NASH through Yuhan deal
BioCentury
Mon, 07/1/19 - 10:47 pm
Tags:
Boehringer Ingelheim, NASH, Yuhan
FDA fast-tracks BI, Lilly's Jardiance in chronic heart failure
Fierce Pharma
Wed, 06/26/19 - 04:59 pm
Tags:
Eli Lilly, Boehringer Ingelheim, Jardiance, chronic heart failure, fast track
Boehringer leads investment in digital therapy for myopia
Pharmaforum
Fri, 06/21/19 - 09:48 am
Tags:
Dopavision, Boehringer Ingelheim, myopia, digital medicine, digital therapy
Boehringer, OSE doses first patient in phase 1 trial of SIRPα antagonist monoclonal antibody
Pharmaceutical Business Review
Tue, 06/18/19 - 09:56 am
Tags:
Boehringer Ingelheim, OSE Immuotherapeutics, clinical trials, BI 765063, solid tumors
Boehringer Ingelheim opens inhaler plant with 200 jobs
Fierce Pharma
Mon, 06/17/19 - 11:34 pm
Tags:
Boehringer Ingelheim, inhalers, drug manufacturing, Spain
ADA: Lilly, Boehringer's DPP-4 drug Tradjenta ties generic rival in heart safety study
Fierce Pharma
Tue, 06/11/19 - 12:06 pm
Tags:
Eli Lilly, Boehringer Ingelheim, ADA, diabetes, Tradjenta
Boehringer Ingelheim, Gubra to develop anti-obesity peptide poly-agonists
Pharmaceutical Business Review
Thu, 05/30/19 - 10:05 am
Tags:
obesity, peptide poly-agonists, Boehringer Ingelheim, Gubra
Boehringer looks to enhance COPD care with new registry
Pharmaforum
Fri, 05/24/19 - 10:52 am
Tags:
Boehringer Ingelheim, COPD, patients, patient registry
AbbVie stock up 1.3% after announcing resolution to litigation over Humira in the U.S.
Marketwatch
Tue, 05/14/19 - 09:31 am
Tags:
AbbVie, biosimilars, Humira, patents, Boehringer Ingelheim
Researchers warn about gangrene cases in patients on SGLT2 diabetes drugs
Fierce Pharma
Thu, 05/9/19 - 11:04 pm
Tags:
gangrene, diabetes, JNJ, Invokana, AstraZeneca, Farxiga, Eli Lilly, Boehringer Ingelheim, Jardiance
BI and Lilly's diabetes drug Jardiance reverses heart failure in animal models
Fierce Biotech
Fri, 04/19/19 - 10:34 am
Tags:
Eli Lilly, Boehringer Ingelheim, Jardiance, type 2 diabetes, heart failure

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.